Go Pro

Pito Chickering Analyst Performance

Sr. sell-side analyst at Deutsche Bank Aktiengesellschaft

Pito Chickering is a stock analyst at Deutsche Bank Aktiengesellschaft in the healthcare sector, covering 13 publicly traded companies. Over the past year, Pito Chickering has issued 9 stock ratings, including buy and hold recommendations. While full access to Pito Chickering's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Pito Chickering's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
25 Last 7 Years
Buy Recommendations
80.00% 20 Buy Ratings
Companies Covered
13 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy80.0%20 ratings
Hold20.0%5 ratings
Sell0.0%0 ratings

Out of 25 total stock ratings issued by Pito Chickering at Deutsche Bank Aktiengesellschaft, the majority (80.0%) have been Buy recommendations, followed by 20.0% Hold.

Exchange Coverage

ExchangePercentageCount
NYSE
61.5% of companies on NYSE
8 companies
NASDAQ
38.5% of companies on NASDAQ
5 companies

Pito Chickering, an analyst at Deutsche Bank Aktiengesellschaft, currently covers 13 companies listed on NYSE and NASDAQ, with the majority traded on NYSE.

Coverage Focus

Sector IconSectorPercentage
Healthcare
13 companies
100.0%

Pito Chickering of Deutsche Bank Aktiengesellschaft specializes in stock coverage within the Healthcare sector.

Coverage Industries

IndustryPercentage
HEALTHCARE PROVIDERS & SERVICES
9 companies
69.2%
HEALTHCARE EQUIPMENT & SUPPLIES
4 companies
30.8%

Pito Chickering's Ratings History at Deutsche Bank Aktiengesellschaft

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
DaVita Inc. stock logo
DVA
DaVita
8/5/2026Reiterated Rating$186.71$265.00Buy
Option Care Health, Inc. stock logo
OPCH
Option Care Health
7/30/2026Reiterated Rating$23.93$24.00Hold
Option Care Health, Inc. stock logo
OPCH
Option Care Health
7/30/2026Downgrade$23.93$24.00Hold
DaVita Inc. stock logo
DVA
DaVita
5/6/2026Upgrade$156.98$220.00Buy
HCA Healthcare, Inc. stock logo
HCA
HCA Healthcare
1/28/2026Boost Price Target$506.29$558.00Buy
Medline stock logo
MDLN
Medline
1/12/2026Initiated Coverage$40.52$40.00Hold
Option Care Health, Inc. stock logo
OPCH
Option Care Health
12/9/2025Boost Price Target$30.59$36.00Buy
Acadia Healthcare Company, Inc. stock logo
ACHC
Acadia Healthcare
12/3/2025Lower Price Target$16.49$20.00Buy
BrightSpring Health Services, Inc. stock logo
BTSG
BrightSpring Health Services
9/8/2025Set Price Target$26.17$30.00Buy
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
7/25/2025Boost Price Target$75.68$94.00Buy
Quest Diagnostics Incorporated stock logo
DGX
Quest Diagnostics
7/23/2025Boost Price Target$175.35$178.00Hold